MedPath

Collaborative Care Model on Type 2 Diabetic Patients

Not Applicable
Completed
Conditions
Type2 Diabetes
Interventions
Behavioral: collaborative care
Registration Number
NCT03553862
Lead Sponsor
National University of Singapore
Brief Summary

The purpose of this study is to determine the effectiveness of the collaborative care model in Singapore in which clinical pharmacists, nurses and dietitians are active participants who collaborate with physicians in caring for patients with Type 2 diabetes mellitus (DM).Since DM is a cardiovascular risk equivalent, co-morbidities such as hypertension (HTN) and dyslipidaemia (DLP) will also be evaluated to assess the holistic care provided for the investigator's patients afflicted with these top chronic diseases in Singapore.

Detailed Description

Specifically, this study aims to evaluate the effectiveness of an integrated collaborative care model comprising of a healthcare team (physician, clinical pharmacist, nurse, and/or dietitian) compared to the usual or conventional healthcare model (physician-centered care) mainly in the clinical, humanistic and economic outcomes.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
255
Inclusion Criteria
  • Patients aged ≥ 21 years with Type 2 DM (HbA1c > 7%) and polypharmacy (≥ 5 medications) will be eligible for this study.
Exclusion Criteria
  • Patients with Type 1 DM or who are unable to communicate independently in English, Chinese or Malay will be excluded from this study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Interventioncollaborative careThe intervention arm will receive collaborative care from a team of healthcare professionals that consists of pharmacist, physicians, nurses and dietitians. Patients in the intervention group will also receive clinical interventions carried out by the pharmacist.
Primary Outcome Measures
NameTimeMethod
Change from baseline Systolic Blood Pressure (SBP) at 12-month12-month

Change of SBP in mmHg

Change from baseline Low-density lipoprotein (LDL) at 12-month12-month

Changes of LDL in mg/dL

Change from baseline High-density lipoprotein (HDL) at 12-month12-month

Changes of HDL in mg/dL

Change from baseline Total cholesterol (TC) at 12-month12-month

Changes of TC in mg/dL

Change from baseline Glycerides (TG) at 12-month12-month

Changes of TG in mg/dL

Incidence of hypoglycaemia12-month

Incidence of hypoglycaemia

Change from baseline Body mass index (BMI) at 6-monthbaseline and 6-month

Change of BMI in kg/m\^2

Change from baseline Glycated Haemoglobin (HbA1c) at 6-monthbaseline and 6-month

Change of HbA1c in %

Changes from baseline Systolic Blood Pressure (SBP) at 6-monthbaseline and 6-month

Change of SBP in mmHg

Change from baseline Body mass index (BMI) at 12 months12-month

Change BMI in kg/m\^2

Change from baseline Glycated Haemoglobin (HbA1c) at 12-month12-month

Changes of HbA1c in %

Change from baseline Low-density lipoprotein (LDL) at 6-monthbaseline and 6-month

Change of LDL in mg/dL

Change from baseline High-density lipoprotein (HDL) at 6-monthbaseline and 6-month

Change of HDL in mg/dL

Change from baseline Total cholesterol (TC) at 6-monthbaseline and 6-month

Change of TC in mg/dL

Change from baseline Glycerides (TG) at 6-monthbaseline and 6-month

Changes of TG in mg/dL

Secondary Outcome Measures
NameTimeMethod
The 5-level EQ-5D version (5Q-5D-5L)12-month

5Q-5D-5L is a questionnaire containing 5 dimensions (mobility, self-care, usual activities, pain/discomfort and anxiety/depression) with 5 levels (no problems, slight problems, moderate problems, severe problems and extreme problems) for the patients to indicate their health stage.

Audit of Diabetes Dependent Quality of Life (ADDQoL)12-month

The ADDQoL is a 19-item questionnaire measuring the effects of diabetes and its treatment on individuals' quality of life.

The Problem Area in Diabetes (PAID)12-month

The PAID is a valid and reliable 20-item questionnaire measuring diabetes-related distress with a five-point Likert scale that ranges from 0 (not a problem) to 4 (serious problem).

Summary of Diabetes Self-Care Activities (SDSCA)12-month

The SDSCA measure is a brief self-report questionnaire of diabetes self-management that includes 14 items assessing the following aspects of the diabetes regimen: general dies, specific diet, exercise, blood-glucose testing, foot care, and smoking.

Self-report Hypoglycaemia Question12-month

It is 5-item questionnaire for the patients with diabetes to self-assess their symptoms of hypoglycaemia.

Work Productivity and Activity Impairment questionnaire, General Health version (WPAI-GH)12-month

The WPAI-GH is a 6-item questionnaire measuring absenteeism, presenteeism, overall work productivity loss, and daily activity impairment with a 10-point scale that range from 0 (no effect on daily activities) to 10 (serious effect on daily activities).

Trial Locations

Locations (1)

Chua Chu Kang Polyclinic

🇸🇬

Singapore, Singapore

© Copyright 2025. All Rights Reserved by MedPath